Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 9/2015

01-09-2015 | Letter to the Editor

Synchronous Hodgkin’s lymphoma and schwannomas mimicking refractory Hodgkin’s lymphoma

Authors: Onno C. Leeksma, Rick L. M. Haas, Frederik N. Hofman, Theo J. Hulsebos, Theo A. M. van Os, Aart Brutel de la Rivière

Published in: Annals of Hematology | Issue 9/2015

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Fisher PM, Dodwell DJ, Bridges LR et al (1994) Malignant schwannoma following treatment for Hodgkin’s disease. Clin Oncol (R Coll Radiol) 6:204–205CrossRef
2.
Watine O, Morel P, Bauters F et al (1995) Thoracic tumors after treatment for Hodgkin disease. Ann Chir 49:225–231PubMed
3.
Morbidini-Gaffney S, Alpert TE, Hatoum GF et al (2005) Benign pleural schwannoma secondary to radiotherapy for Hodgkin disease. Am J Clin Oncol 28:640–641PubMedCrossRef
4.
Rodriguez FJ, Stratakis CA, Evans DG (2012) Genetic predisposition to peripheral nerve neoplasia: diagnostic criteria and pathogenesis of neurofibromatoses, Carney complex, and related syndromes. Acta Neuropathol 123:349–367PubMedCentralPubMedCrossRef
5.
Seminog OO, Goldacre MJ (2013) Risk of benign tumours of nervous system, and of malignant neoplasms, in people with neurofibromatosis: population based record-linkage stud. Br J Cancer 108:193–198PubMedCentralPubMedCrossRef
6.
Dang JD, Cohen PR (2010) Segmental neurofibromatosis and malignancy. Skinmed 8:156–159PubMed
7.
Evans GR, Lloyd SK, Ramsden RT (2011) Neurofibromatosis type 2. Adv Otorhinolaryngol 70:91–98PubMed
8.
9.
Yuge M, Nagai H, Uchida T et al (2000) HSNF5/INI1 gene mutations in lymphoid malignancy. Cancer Genet Cytogenet 122:37–42PubMedCrossRef
10.
Piotrowski A, Xie J, Poplawski AB et al (2014) Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas. Nat Genet 46:182–187PubMedCentralPubMedCrossRef
Metadata
Title
Synchronous Hodgkin’s lymphoma and schwannomas mimicking refractory Hodgkin’s lymphoma
Authors
Onno C. Leeksma
Rick L. M. Haas
Frederik N. Hofman
Theo J. Hulsebos
Theo A. M. van Os
Aart Brutel de la Rivière
Publication date
01-09-2015
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 9/2015
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-015-2408-x

Other articles of this Issue 9/2015

Annals of Hematology 9/2015 Go to the issue

Letter to the Editor

A novel MYH9 mutation in a patient with MYH9 disorders and platelet size-specific effect of romiplostim on macrothrombocytopenia

Original Article

Hospital population screening reveals overrepresentation of CD5− monoclonal B-cell lymphocytosis and monoclonal gammopathy of undetermined significance of IgM type

Original Article

Desmopressin improves platelet function in uremic patients taking antiplatelet agents who require emergent invasive procedures

Original Article

Comparison of consolidation strategies in acute myeloid leukemia: high-dose cytarabine alone versus intermediate-dose cytarabine combined with anthracyclines

Original Article

HES1 activation suppresses proliferation of leukemia cells in acute myeloid leukemia

Original Article

High numbers of CD68+ tumor-associated macrophages correlate with poor prognosis in extranodal NK/T-cell lymphoma, nasal type
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits